CAMBRIDGE, MA — June 3, 2013 – Knome Inc., the human genome interpretation company, today announced that its Services division will now provide its clients with advanced HLA typing capabilities as part of its whole genome and exome interpretation offerings. These capabilities will be powered by Omixon’s Targeted HLA Typing … more
Partnership to bring accurate and fast genome analysis to translational researchers CAMBRIDGE, MA – May 6, 2013 – Knome Inc., the genome interpretation company, and Real Time Genomics, Inc., the genome analytics company, today announced that the Real Time Genomics (RTG) Variant platform will be integrated into every shipment of the knoSYS™100 interpretation … more
For those who missed us, allow us to fill you in on the excitement… A contingent of Knomies went out to San Francisco from November 6-10 for the annual meeting of the American Society of Human Genetics. There we had the pleasure of engaging with a number of geneticists, genomicists, … more
So it will probably be gone by the time most of you read this, but Google just honored Rosalind Franklin with her very own Google doodle on her birthday. As you may have noticed from the stylized image of photograph 51 on our homepage, we are big Rosalind fans around … more
An excerpt of an interesting article featuring Knome… The price of sequencing a person’s genome — putting in order all three billion base pairs of DNA in a set of human chromosomes — keeps dropping. But interpreting the billions of letters in a person’s DNA blueprint for use in medicine, … more
An excerpt of an interesting article mentioning Knome [emphasis ours]… Remember a couple of years ago when people commemorated the 10-year anniversary of the first draft human genome sequencing? The storyline then, in 200, was that we all went off to genome camp and only came home with a lousy … more
An excerpt of an interesting article mentioning Knome [emphasis ours]: …Cambridge, Massachusetts–based Knome made one of the splashiest entries into the field, but has now turned entirely to contract research. The company began providing DTC whole-genome sequencing to independently wealthy individuals at a time when the price was still sky … more
Knome does not provide medical advice, diagnosis or treatment. Analyses and reports provided by Knome are for informational purposes only and are subject to change. Knome's products and services are for research use only, not for use in diagnostic procedures.